SCHEMBL6633338

SCHEMBL6633338

CN(C)[C@@H](CS(=O)(=O)Cc1ccccc1)C(=O)NCCCCC(O)c1nc2ccccc2s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.43
HDAC3 O15379 2/20 0.41
HDAC4 P56524 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC7 Q8WUI4 2/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC10 Q969S8 2/20 0.41
HDAC11 Q96DB2 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
HDAC9 Q9UKV0 2/20 0.41
HDAC5 Q9UQL6 2/20 0.41
LIPC P11150 10/20 0.39
LIPG Q9Y5X9 7/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RAB9A P51151 1/20 0.39
HPGD P15428 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALOX5 P09917 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6062888 1.00 MAPK1 (0.43) MAPK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6629203 0.90 MAPK1 (0.42) MAPK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6063017 0.90 MAPK1 (0.42) MAPK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6630164 0.86 HDAC6 (0.45) MAPK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6630166 0.86 HDAC6 (0.45) MAPK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6633085 0.85 HDAC3 (0.43) MAPK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6063224 0.85 HDAC3 (0.43) MAPK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6062843 0.85 NPC1 (0.45) MAPK1NPC1ALDH1A1RAB9AHPGD
SCHEMBL6631489 0.81 HDAC3 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6629847 0.81 PTPN1 (0.38) HDAC6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP claimed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO claimed
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP disclosed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed